Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Ulbrich

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
Selective Cancer Therapeutics|January 1, 1991
Synthetic polymers conjugated to monoclonal antibodies: vehicles for tumour-targeted drug deliveryL W Seymour, P A Flanagan, A al-Shamkhani, et al.
Gene Therapy|August 5, 2000
A versatile system for receptor-mediated gene delivery permits increased entry of DNA into target cells, enhanced delivery to the nucleus and elevated rates of transgene expressionK D Fisher, K Ulbrich, V Subr, et al.
Biochimica Et Biophysica Acta|May 23, 1998
Novel vectors for gene delivery formed by self-assembly of DNA with poly(L-lysine) grafted with hydrophilic polymersV Toncheva, M A Wolfert, P R Dash, et al.
Neoplasma|August 2, 2001
Polymer conjugated bovine seminal ribonuclease inhibits growth of solid tumors and development of metastases in miceJ Soucek, P Poucková, M Zadinová, et al.
Bioconjugate Chemistry|September 20, 2000
Antiproliferative effect of a lectin- and anti-Thy-1.2 antibody-targeted HPMA copolymer-bound doxorubicin on primary and metastatic human colorectal carcinoma and on human colorectal carcinoma transfected with the mouse Thy-1.2 geneB Ríhová, M Jelínková, J Strohalm, et al.
Journal of Medicinal Chemistry|September 29, 2006
A novel class of potent nonglycosidic and nonpeptidic pan-selectin inhibitorsHolger K Ulbrich, Andreas Luxenburger, Philip Prech, et al.
Bioconjugate Chemistry|November 24, 1999
Polyelectrolyte vectors for gene delivery: influence of cationic polymer on biophysical properties of complexes formed with DNAM A Wolfert, P R Dash, O Nazarova, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 21, 2000
Polymeric drugs based on conjugates of synthetic and natural macromolecules. II. Anti-cancer activity of antibody or (Fab')(2)-targeted conjugates and combined therapy with immunomodulatorsB Ríhová, M Jelínková, J Strohalm, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 8, 2008
Doxorubicin release is not a prerequisite for the in vitro cytotoxicity of HPMA-based pharmaceuticals: in vitro effect of extra drug-free GlyPheLeuGly sequencesB Ríhová, J Strohalm, O Hovorka, et al.
Scandinavian Journal of Immunology|June 15, 2005
Induction of systemic antitumour resistance with targeted polymersB Rihova, J Strohalm, M Kovar, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
Selective Cancer Therapeutics|January 1, 1991
Synthetic polymers conjugated to monoclonal antibodies: vehicles for tumour-targeted drug deliveryL W Seymour, P A Flanagan, A al-Shamkhani, et al.
Gene Therapy|August 5, 2000
A versatile system for receptor-mediated gene delivery permits increased entry of DNA into target cells, enhanced delivery to the nucleus and elevated rates of transgene expressionK D Fisher, K Ulbrich, V Subr, et al.
Biochimica Et Biophysica Acta|May 23, 1998
Novel vectors for gene delivery formed by self-assembly of DNA with poly(L-lysine) grafted with hydrophilic polymersV Toncheva, M A Wolfert, P R Dash, et al.
Neoplasma|August 2, 2001
Polymer conjugated bovine seminal ribonuclease inhibits growth of solid tumors and development of metastases in miceJ Soucek, P Poucková, M Zadinová, et al.
Bioconjugate Chemistry|September 20, 2000
Antiproliferative effect of a lectin- and anti-Thy-1.2 antibody-targeted HPMA copolymer-bound doxorubicin on primary and metastatic human colorectal carcinoma and on human colorectal carcinoma transfected with the mouse Thy-1.2 geneB Ríhová, M Jelínková, J Strohalm, et al.
Journal of Medicinal Chemistry|September 29, 2006
A novel class of potent nonglycosidic and nonpeptidic pan-selectin inhibitorsHolger K Ulbrich, Andreas Luxenburger, Philip Prech, et al.
Bioconjugate Chemistry|November 24, 1999
Polyelectrolyte vectors for gene delivery: influence of cationic polymer on biophysical properties of complexes formed with DNAM A Wolfert, P R Dash, O Nazarova, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 21, 2000
Polymeric drugs based on conjugates of synthetic and natural macromolecules. II. Anti-cancer activity of antibody or (Fab')(2)-targeted conjugates and combined therapy with immunomodulatorsB Ríhová, M Jelínková, J Strohalm, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 8, 2008
Doxorubicin release is not a prerequisite for the in vitro cytotoxicity of HPMA-based pharmaceuticals: in vitro effect of extra drug-free GlyPheLeuGly sequencesB Ríhová, J Strohalm, O Hovorka, et al.
Scandinavian Journal of Immunology|June 15, 2005
Induction of systemic antitumour resistance with targeted polymersB Rihova, J Strohalm, M Kovar, et al.
Pageof 10